Displaying drugs 726 - 750 of 1458 in total
Vatalanib
Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under investigation for the treatment of solid tumors.
Investigational
Laromustine
VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.
Investigational
CP-744809
Experimental
Cloperastine
Cloperastine is a cough suppressant that acts on the central nervous system.
Experimental
Perfosfamide
Perfosfamide has been used in trials studying the treatment of Lymphoma, Neuroblastoma, and Multiple Myeloma and Plasma Cell Neoplasm.
Investigational
2-Bromo-6-chloro-purine
Experimental
6-Chloro-2-fluoropurine
Experimental
Arylacenamide
Arylacenamide (SR31747) is a peripheral [sigma] ligand that binds four proteins in human cells, i.e. SRBP-1, [sigma]-2, HSI and its relative SRBP-2. It is a dual agent with both immunomodulatory and antiproliferative activities.
Investigational
Eberconazole
Experimental
Mefenorex
Experimental
2',6'-Dichloro-Biphenyl-2,6-Diol
Experimental
4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One
Experimental
Carisbamate
Carisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence.
Investigational
p-Chlorobenzoic acid
Experimental
(S)-econazole
Experimental
Trofosfamide
Trofosfamide has been used in trials studying the treatment of Ependymomas, Medulloblastomas, Sarcoma, Soft Tissue, Supratentorial PNETs, and Recurrent Brain Tumors.
Investigational
Teclozan
Teclozan is an antiprotozoal agent employed typically as a therapy to treat protozoan infections.
Experimental
Tolonidine
Experimental
Displaying drugs 726 - 750 of 1458 in total